carbamates has been researched along with Myasthenia Gravis in 2 studies
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| ", pyridostigmine bromide, neostigmine bromide) of carbamate origin are used in the early treatment of Myasthenia gravis (MG) to block acetylcholinesterase (AChE) native function and conserve efficient amount of acetylcholine for decreasing number of nicotinic receptors." | 3.76 | Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications. ( Dohnal, V; Dolezal, M; Holas, O; Hrabinova, M; Jung, YS; Komloova, M; Kuca, K; Musilek, K; Nachon, F; Pohanka, M; Zavadova, V, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Musilek, K | 1 |
| Komloova, M | 1 |
| Zavadova, V | 1 |
| Holas, O | 1 |
| Hrabinova, M | 1 |
| Pohanka, M | 1 |
| Dohnal, V | 1 |
| Nachon, F | 1 |
| Dolezal, M | 1 |
| Kuca, K | 1 |
| Jung, YS | 1 |
| PATEISKY, K | 1 |
| HERZFELD, E | 1 |
| STUMPF, C | 1 |
2 other studies available for carbamates and Myasthenia Gravis
| Article | Year |
|---|---|
Preparation and in vitro screening of symmetrical bispyridinium cholinesterase inhibitors bearing different connecting linkage-initial study for Myasthenia gravis implications.
Topics: Acetylcholinesterase; Binding Sites; Butyrylcholinesterase; Carbamates; Catalytic Domain; Cholineste | 2010 |
[Effect of polymethylene-bis-(N-methyl-carbamic acid-m-trimethylammonium-phenol) BC 40, BC 47, BC 48 on cholinesterase activity and muscle activity in myasthenia gravis pseudoparalytica].
Topics: Carbamates; Cholinesterases; Muscles; Myasthenia Gravis; Neostigmine; Phenols | 1957 |